Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 7;11:3951. doi: 10.1038/s41467-020-17449-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — a HeLa cells were treated with siRNA against DONSON or FANCM or both. They were exposed to Dig-TMP/UVA and incubated with CldU, then IdU. Fibers were prepared and patterns displayed by immunofluorescence against the analogues and immunoquantum detection (Q dot 655, in red) for Dig-tagged ICLs. Representative patterns are shown. b Quantitation of pattern distribution. Fibers with ICL encounters: NT = 417; siDONSON = 432; siFANCM = 417; siDONSON + siFANCM = 385, from three independent replicates. Data are mean ± s.d. c IP immunoblot of chromatin proteins from cells expressing GFP (panels 1, 2) or GFP-DONSON (panels 3, 4) exposed to UVA (−) or TMP/UVA (+). The identity of the proteins is indicated. The amounts of PSF1 and CDC45 in the two samples were quantitated. Representative blot (n = 3). Data are mean ± s.d. d PLA test of the influence of ATR inhibition on GFP-DONSON interactions with pMCM2S108, MCM2, and MCM5. Number of nuclei: PLA between GFP-DONSON and pMCM2 in cells treated with UVA = 58, TMP/UVA = 94, TMP/UVA + ATRi = 55; PLA between GFP-DONSON and MCM2 in UVA = 95, TMP/UVA = 89, TMP/UVA + ATRi = 93; PLA between GFP-DONSON and MCM5 in UVA = 88, TMP/UVA = 79, TMP/UVA+ATRi = 73; from three biological replicates. Data are mean ± s.e.m. e PLA assessing the influence of ATR inhibition on GFP-DONSON interactions with CDC45 and PSF1. Scored nuclei of PLA between GFP-DONSON and CDC45 in UVA = 70, TMP/UVA = 71, TMP/UVA + ATRi = 73; scored nuclei of PLA between GFP-DONSON and PSF1 in UVA = 71, TMP/UVA = 64, TMP/UVA + ATRi = 77; from three biological replicates. Data are mean ± s.e.m. f Influence of ATR inhibition on the PLA between GFP-DONSON and Dig-tagged ICLs. Scored nuclei: Vehicle = 72, ATRi = 87, three biological replicates. Data are mean ± s.e.m. For replication pattern frequency experiments and Western blotting image analysis (a, c), a two-sided unpaired t test was used to calculate P-values. For PLA experiments (d–f), a two-sided Mann–Whitney rank-sum test was used to determine if differences were significant. NS: not significant: P > 0.05. Source data are provided as a Source Data file.